o Cross-Licensing Results in Commercially Available Consolidated Patent Portfolio for Fluorescent Protein Imaging o Near Term Collaboration Plans Involving Imaging Consumables HOPKINTON, Mass. and SAN DIEGO, Calif., February 26, 2008 -- Caliper Life Sciences (NASDAQ: CALP) and AntiCancer, Inc. today announced that they have entered into an agreement to establish a cross-licensing relationship ...
Lawyer Central Also Recommends These Stories: